Bid Publish Date
20-Dec-2024, 8:26 am
Bid End Date
10-Jan-2025, 9:00 am
Value
₹3,89,632
Location
Progress
Quantity
73974
Category
Common Cold Tab Cetirizine 5 to10 mg and Paracetamol 500 mg and Pseudoephedrine 30 to 60 mg
Bid Type
Two Packet Bid
A tender has been published for Indian Army Common Cold Tab Cetirizine 5 to10 mg and Paracetamol 500 mg and Pseudoephedrine 30 to 60 mg, Paracet in JAMMU, JAMMU & KASHMIR. Quantity: 73974 by. Submission Deadline: 10-01-2025 09: 00: 00. Check eligibility and apply.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
OTHER
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Common Cold Tab Cetirizine 5 to10 mg and Paracetamol 500 mg and Pseudoephedrine 30 to 60 mg
As per BOQ specification
Paracetamol 500mg Tab
As per BOQ specification
Paracetamol Syp 125 mg per 5 ml bottle of 60 ml
As per BOQ specification
Tinidazole 500 mg Tab
As per BOQ specification
Hydroxyurea 500 mg Cap
As per BOQ specification
Tranexamic Acid 500 mg per 5 ml Inj
As per BOQ specification
Aspirin 75 mg Tab
As per BOQ specification
Betamethasone Dipropionate USP 0.05mg and Gentamycin Sulphate 1mg per gm tube of 5gm
As per BOQ specification
Framycetin sulphate BP 1 percent cream 20 gm
As per BOQ specification
Silver sulphadiazine 1 percent cream w per v jar of 500 gms
As per BOQ specification
Dicyclomine HCl 20mg Inj
As per BOQ specification
Norflox 400 mg and Tinidazole 600mg Tab
As per BOQ specification
Cetirizine Syp 5mg per 5ml bott of 60 ml
As per BOQ specification
Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per metred dose in CFC free MDI
As per BOQ specification
Ipratropium Bromide Respirator soln 500 mcg per 2 ml respule
As per BOQ specification
Levo Salbutamol aerosol pack of 200 metered doses each metered dose supplies 50 mcg of Levo Salbutamol
As per BOQ specification
Levo Salbutamol Sulphate 2.5 ml containing 1.25 mg Respule
As per BOQ specification
Cough expectorant syp 5 ml containing Diphenhydramine HCl 14.08mg Ammonium Chloride 0.138 gm Sodium Citrate 57.03mg Menthol 1.14 mg in flavoured syp base bott of 100 to 110 ml
As per BOQ specification
Multi Vit Inj IV 2 to 10 ml with minimum constituents having Thiamine B1 30mg per ml Pyridoxine B6 30mg per ml and B12 Cyanocobalamin to 300 mcg per ml
As per BOQ specification
Capsaicin Gel Tube of 20 gm
As per BOQ specification
Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml
As per BOQ specification
Azithromycin Dihydrate 250 mg Tab per Cap
As per BOQ specification
Clindamycin 300 mg Cap
As per BOQ specification
Norfloxacin 400 mg Tab
As per BOQ specification
Paracetamol with Cysteine HCl monohydrate infusion 1000 mg per 100 ml
As per BOQ specification
Syp Zinc 20 mg per 5 ml bottle of 100 ml
As per BOQ specification
Azithromycin 500 mg Tab
As per BOQ specification
Disodium Hydrogen Syp
As per BOQ specification
Pirfenidone 200 mg Tab
As per BOQ specification
Cefuroxime Axetil 500 mg Tab
As per BOQ specification
Midazolam 5 mg 1 ml Inj
As per BOQ specification
Deflazacort 6 mg Tab
As per BOQ specification
Diclofenac Sodium 50 mg enteric coated Tab
As per BOQ specification
Diclofenac 25 mg per ml IP 3 ml Inj
As per BOQ specification
Etoricoxib 120 mg Tab
As per BOQ specification
Piroxicam 20 mg Tab
As per BOQ specification
Tramadol HCl 50 mg Cap per Tab
As per BOQ specification
Suspension per Syp Fexofenadine 30 mg per 5ml 60 ml bottle
As per BOQ specification
Dexamethasone Sodium Phosphate 4.4 mg Equivalent to Dexamethasone Phosphate 4 mg per ml 2 ml Inj
As per BOQ specification
Pheniramine Maleate Inj 22.75 mg per ml amp of 2 ml
As per BOQ specification
Lorazepam 2 mg per ml 2 ml Inj
As per BOQ specification
Phenobarbitone 30 mg Tab
As per BOQ specification
Baclofen 10 mg Tab
As per BOQ specification
Albendazole Syp each 5 ml containing 200 mg bott of 10 ml
As per BOQ specification
Diethylcarbamazine 50mg Tab
As per BOQ specification
Clotrimazole mouth paint 1 percent bottle of 15 ml
As per BOQ specification
Imatinib Mesylate 100mg Cap
As per BOQ specification
Amantadine 100 mg Cap
As per BOQ specification
Acenocoumarol 4 mg Tab
As per BOQ specification
Carvedilol 3.125mg Tab
As per BOQ specification
Diltiazem 5mg per ml Inj
As per BOQ specification
Esmolol 100 mg 10 ml Inj
As per BOQ specification
Clonidine 100 mcg Tab
As per BOQ specification
Hydrochlorothiazide 25mg
As per BOQ specification
Labetalol HCl 5mg per ml 4ml Inj
As per BOQ specification
Prazosin 5 mg sustained release per slow release Tab
As per BOQ specification
Mometasone 0.1 percent tube of 10 gm
As per BOQ specification
Frusemide 20 mg 2 ml Inj
As per BOQ specification
Ranitidine HCl 50 mg 2 ml Inj
As per BOQ specification
Domperidone 10 mg Tab
As per BOQ specification
Bisacodyl 5 mg Tab
As per BOQ specification
Clotrimazole Vaginal Pessary 100mg
As per BOQ specification
Povidone Iodine 200 mg Pessary
As per BOQ specification
Magnesium sulphate 50 percent w per v Inj
As per BOQ specification
Glibenclamide 5mg Tab
As per BOQ specification
Pioglitazone Hydrochloride 15 mg Tab
As per BOQ specification
Alendronate Sodium 70mg Tab
As per BOQ specification
Alfacalcidol Vit D3 0.25mcg Cap
As per BOQ specification
Ciprofloxacin 0.3 percent eye drops of 3mg per ml bott of 5 ml
As per BOQ specification
Ciprofloxacin HCl 0.3 percent and Dexamethasone 0.1 percent bott of 5ml
As per BOQ specification
Xylometazoline HCl 0.05 percent w per v nasal solution for paed use bott of 10ml
As per BOQ specification
Cyproheptadine HCl 2 mg per 5 ml bott of 100 ml
As per BOQ specification
Duloxetine 20 mg Tab
As per BOQ specification
Lorazepam 1 mg Tab
As per BOQ specification
Sertraline 50 mg Tab
As per BOQ specification
Zolpidem 10 mg Tab
As per BOQ specification
Etophylline BP 84.7 mg and Theophylline IP 25.3 mg per ml 2 ml Inj
As per BOQ specification
Dextrose Inj 25 percent 25 ml Inj
As per BOQ specification
Potassium Chloride Liquid 20 percent bott of 200 ml
As per BOQ specification
Multivitamin drops with constituents having Vit A Vit B1 B2 B6 Vit C Vit D bottle of 15ml osages as per recommended daily allowances
As per BOQ specification
Methyl Prednisolone Sodium Succinate 40 mg Inj
As per BOQ specification
Monteleukast 5 mg Tab
As per BOQ specification
Cefuroxime 250 mg Tab
As per BOQ specification
Cefuroxime susp 125 mg per 5 ml bott of 30 ml
As per BOQ specification
Levofloxacin 500 mg Tab
As per BOQ specification
Tab Quetiapine 100 mg
As per BOQ specification
Pancreatic Enzyme supplement with a Lipase content of 25000 units or more Cap
As per BOQ specification
Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCl 10 mg
As per BOQ specification
Telmisartan 40 mg and Amlodipine 10 mg Tab
As per BOQ specification
Tab Thyroxine Sodium 12.5 mcg
As per BOQ specification
Tab Paracetamol 650 mg
As per BOQ specification
Antacid chewable containing dried Aluminium Hydroxide IP 250 mg Mag Hydroxide NF 250 mg Methyl Polysiloxane 50 mg Tab
As per BOQ specification
Para dichlorobenzene 2 percent w per v Benzocaine 2.7 percent w per v Chlorbutol 5 percent Turpentine oil 15 percent w per v bott of 10 ml
As per BOQ specification
Nitrofurantoin 100 mg Tab
As per BOQ specification
Omeprazole 20 mg Domperidone 10 mg Cap
As per BOQ specification
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Common Cold Tab Cetirizine 5 to10 mg and Paracetamol 500 mg and Pseudoephedrine 30 to 60 mg | As per BOQ specification | 7,500 | no | dglp171gem | 30 | |
| 2 | Paracetamol 500mg Tab | As per BOQ specification | 4,500 | no | dglp171gem | 30 | |
| 3 | Paracetamol Syp 125 mg per 5 ml bottle of 60 ml | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 4 | Tinidazole 500 mg Tab | As per BOQ specification | 2,100 | no | dglp171gem | 30 | |
| 5 | Hydroxyurea 500 mg Cap | As per BOQ specification | 450 | no | dglp171gem | 30 | |
| 6 | Tranexamic Acid 500 mg per 5 ml Inj | As per BOQ specification | 90 | amp or vial | dglp171gem | 30 | |
| 7 | Aspirin 75 mg Tab | As per BOQ specification | 9,000 | no | dglp171gem | 30 | |
| 8 | Betamethasone Dipropionate USP 0.05mg and Gentamycin Sulphate 1mg per gm tube of 5gm | As per BOQ specification | 60 | tube | dglp171gem | 30 | |
| 9 | Framycetin sulphate BP 1 percent cream 20 gm | As per BOQ specification | 300 | tube | dglp171gem | 30 | |
| 10 | Silver sulphadiazine 1 percent cream w per v jar of 500 gms | As per BOQ specification | 6 | jar | dglp171gem | 30 | |
| 11 | Dicyclomine HCl 20mg Inj | As per BOQ specification | 300 | amp or vial | dglp171gem | 30 | |
| 12 | Norflox 400 mg and Tinidazole 600mg Tab | As per BOQ specification | 3,000 | no | dglp171gem | 30 | |
| 13 | Cetirizine Syp 5mg per 5ml bott of 60 ml | As per BOQ specification | 450 | bott | dglp171gem | 30 | |
| 14 | Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per metred dose in CFC free MDI | As per BOQ specification | 45 | no | dglp171gem | 30 | |
| 15 | Ipratropium Bromide Respirator soln 500 mcg per 2 ml respule | As per BOQ specification | 1,500 | no | dglp171gem | 30 | |
| 16 | Levo Salbutamol aerosol pack of 200 metered doses each metered dose supplies 50 mcg of Levo Salbutamol | As per BOQ specification | 300 | inhaler | dglp171gem | 30 | |
| 17 | Levo Salbutamol Sulphate 2.5 ml containing 1.25 mg Respule | As per BOQ specification | 1,500 | amp or vial | dglp171gem | 30 | |
| 18 | Cough expectorant syp 5 ml containing Diphenhydramine HCl 14.08mg Ammonium Chloride 0.138 gm Sodium Citrate 57.03mg Menthol 1.14 mg in flavoured syp base bott of 100 to 110 ml | As per BOQ specification | 1,500 | bott | dglp171gem | 30 | |
| 19 | Multi Vit Inj IV 2 to 10 ml with minimum constituents having Thiamine B1 30mg per ml Pyridoxine B6 30mg per ml and B12 Cyanocobalamin to 300 mcg per ml | As per BOQ specification | 300 | amp or vial | dglp171gem | 30 | |
| 20 | Capsaicin Gel Tube of 20 gm | As per BOQ specification | 150 | tube | dglp171gem | 30 | |
| 21 | Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml | As per BOQ specification | 150 | bott | dglp171gem | 30 | |
| 22 | Azithromycin Dihydrate 250 mg Tab per Cap | As per BOQ specification | 3,000 | no | dglp171gem | 30 | |
| 23 | Clindamycin 300 mg Cap | As per BOQ specification | 30 | no | dglp171gem | 30 | |
| 24 | Norfloxacin 400 mg Tab | As per BOQ specification | 900 | no | dglp171gem | 30 | |
| 25 | Paracetamol with Cysteine HCl monohydrate infusion 1000 mg per 100 ml | As per BOQ specification | 150 | bott | dglp171gem | 30 | |
| 26 | Syp Zinc 20 mg per 5 ml bottle of 100 ml | As per BOQ specification | 30 | bott | dglp171gem | 30 | |
| 27 | Azithromycin 500 mg Tab | As per BOQ specification | 900 | no | dglp171gem | 30 | |
| 28 | Disodium Hydrogen Syp | As per BOQ specification | 300 | bott | dglp171gem | 30 | |
| 29 | Pirfenidone 200 mg Tab | As per BOQ specification | 180 | no | dglp171gem | 30 | |
| 30 | Cefuroxime Axetil 500 mg Tab | As per BOQ specification | 300 | tab | dglp171gem | 30 | |
| 31 | Midazolam 5 mg 1 ml Inj | As per BOQ specification | 30 | amp or vial | dglp171gem | 30 | |
| 32 | Deflazacort 6 mg Tab | As per BOQ specification | 150 | no | dglp171gem | 30 | |
| 33 | Diclofenac Sodium 50 mg enteric coated Tab | As per BOQ specification | 4,500 | no | dglp171gem | 30 | |
| 34 | Diclofenac 25 mg per ml IP 3 ml Inj | As per BOQ specification | 300 | amp or vial | dglp171gem | 30 | |
| 35 | Etoricoxib 120 mg Tab | As per BOQ specification | 600 | tab | dglp171gem | 30 | |
| 36 | Piroxicam 20 mg Tab | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 37 | Tramadol HCl 50 mg Cap per Tab | As per BOQ specification | 1,500 | no | dglp171gem | 30 | |
| 38 | Suspension per Syp Fexofenadine 30 mg per 5ml 60 ml bottle | As per BOQ specification | 30 | bott | dglp171gem | 30 | |
| 39 | Dexamethasone Sodium Phosphate 4.4 mg Equivalent to Dexamethasone Phosphate 4 mg per ml 2 ml Inj | As per BOQ specification | 90 | amp or vial | dglp171gem | 30 | |
| 40 | Pheniramine Maleate Inj 22.75 mg per ml amp of 2 ml | As per BOQ specification | 150 | amp or vial | dglp171gem | 30 | |
| 41 | Lorazepam 2 mg per ml 2 ml Inj | As per BOQ specification | 45 | amp or vial | dglp171gem | 30 | |
| 42 | Phenobarbitone 30 mg Tab | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 43 | Baclofen 10 mg Tab | As per BOQ specification | 1,500 | no | dglp171gem | 30 | |
| 44 | Albendazole Syp each 5 ml containing 200 mg bott of 10 ml | As per BOQ specification | 120 | bott | dglp171gem | 30 | |
| 45 | Diethylcarbamazine 50mg Tab | As per BOQ specification | 90 | no | dglp171gem | 30 | |
| 46 | Clotrimazole mouth paint 1 percent bottle of 15 ml | As per BOQ specification | 30 | bott | dglp171gem | 30 | |
| 47 | Imatinib Mesylate 100mg Cap | As per BOQ specification | 90 | no | dglp171gem | 30 | |
| 48 | Amantadine 100 mg Cap | As per BOQ specification | 60 | no | dglp171gem | 30 | |
| 49 | Acenocoumarol 4 mg Tab | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 50 | Carvedilol 3.125mg Tab | As per BOQ specification | 3,000 | no | dglp171gem | 30 | |
| 51 | Diltiazem 5mg per ml Inj | As per BOQ specification | 9 | amp or vial | dglp171gem | 30 | |
| 52 | Esmolol 100 mg 10 ml Inj | As per BOQ specification | 15 | amp or vial | dglp171gem | 30 | |
| 53 | Clonidine 100 mcg Tab | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 54 | Hydrochlorothiazide 25mg | As per BOQ specification | 1,800 | tab | dglp171gem | 30 | |
| 55 | Labetalol HCl 5mg per ml 4ml Inj | As per BOQ specification | 30 | amp or vial | dglp171gem | 30 | |
| 56 | Prazosin 5 mg sustained release per slow release Tab | As per BOQ specification | 900 | no | dglp171gem | 30 | |
| 57 | Mometasone 0.1 percent tube of 10 gm | As per BOQ specification | 90 | tube | dglp171gem | 30 | |
| 58 | Frusemide 20 mg 2 ml Inj | As per BOQ specification | 150 | amp or vial | dglp171gem | 30 | |
| 59 | Ranitidine HCl 50 mg 2 ml Inj | As per BOQ specification | 90 | amp or vial | dglp171gem | 30 | |
| 60 | Domperidone 10 mg Tab | As per BOQ specification | 2,400 | no | dglp171gem | 30 | |
| 61 | Bisacodyl 5 mg Tab | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 62 | Clotrimazole Vaginal Pessary 100mg | As per BOQ specification | 150 | no | dglp171gem | 30 | |
| 63 | Povidone Iodine 200 mg Pessary | As per BOQ specification | 90 | no | dglp171gem | 30 | |
| 64 | Magnesium sulphate 50 percent w per v Inj | As per BOQ specification | 150 | amp or vial | dglp171gem | 30 | |
| 65 | Glibenclamide 5mg Tab | As per BOQ specification | 150 | no | dglp171gem | 30 | |
| 66 | Pioglitazone Hydrochloride 15 mg Tab | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 67 | Alendronate Sodium 70mg Tab | As per BOQ specification | 60 | no | dglp171gem | 30 | |
| 68 | Alfacalcidol Vit D3 0.25mcg Cap | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 69 | Ciprofloxacin 0.3 percent eye drops of 3mg per ml bott of 5 ml | As per BOQ specification | 300 | bott | dglp171gem | 30 | |
| 70 | Ciprofloxacin HCl 0.3 percent and Dexamethasone 0.1 percent bott of 5ml | As per BOQ specification | 30 | bott | dglp171gem | 30 | |
| 71 | Xylometazoline HCl 0.05 percent w per v nasal solution for paed use bott of 10ml | As per BOQ specification | 30 | bott | dglp171gem | 30 | |
| 72 | Cyproheptadine HCl 2 mg per 5 ml bott of 100 ml | As per BOQ specification | 75 | bott | dglp171gem | 30 | |
| 73 | Duloxetine 20 mg Tab | As per BOQ specification | 1,500 | no | dglp171gem | 30 | |
| 74 | Lorazepam 1 mg Tab | As per BOQ specification | 90 | no | dglp171gem | 30 | |
| 75 | Sertraline 50 mg Tab | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 76 | Zolpidem 10 mg Tab | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 77 | Etophylline BP 84.7 mg and Theophylline IP 25.3 mg per ml 2 ml Inj | As per BOQ specification | 240 | amp or vial | dglp171gem | 30 | |
| 78 | Dextrose Inj 25 percent 25 ml Inj | As per BOQ specification | 90 | amp or vial | dglp171gem | 30 | |
| 79 | Potassium Chloride Liquid 20 percent bott of 200 ml | As per BOQ specification | 9 | ltr | dglp171gem | 30 | |
| 80 | Multivitamin drops with constituents having Vit A Vit B1 B2 B6 Vit C Vit D bottle of 15ml osages as per recommended daily allowances | As per BOQ specification | 90 | bott | dglp171gem | 30 | |
| 81 | Methyl Prednisolone Sodium Succinate 40 mg Inj | As per BOQ specification | 30 | amp or vial | dglp171gem | 30 | |
| 82 | Monteleukast 5 mg Tab | As per BOQ specification | 3,000 | no | dglp171gem | 30 | |
| 83 | Cefuroxime 250 mg Tab | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 84 | Cefuroxime susp 125 mg per 5 ml bott of 30 ml | As per BOQ specification | 30 | bott | dglp171gem | 30 | |
| 85 | Levofloxacin 500 mg Tab | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 86 | Tab Quetiapine 100 mg | As per BOQ specification | 150 | no | dglp171gem | 30 | |
| 87 | Pancreatic Enzyme supplement with a Lipase content of 25000 units or more Cap | As per BOQ specification | 90 | no | dglp171gem | 30 | |
| 88 | Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCl 10 mg | As per BOQ specification | 900 | no | dglp171gem | 30 | |
| 89 | Telmisartan 40 mg and Amlodipine 10 mg Tab | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 90 | Tab Thyroxine Sodium 12.5 mcg | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 91 | Tab Paracetamol 650 mg | As per BOQ specification | 1,500 | no | dglp171gem | 30 | |
| 92 | Antacid chewable containing dried Aluminium Hydroxide IP 250 mg Mag Hydroxide NF 250 mg Methyl Polysiloxane 50 mg Tab | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 93 | Para dichlorobenzene 2 percent w per v Benzocaine 2.7 percent w per v Chlorbutol 5 percent Turpentine oil 15 percent w per v bott of 10 ml | As per BOQ specification | 60 | bott | dglp171gem | 30 | |
| 94 | Nitrofurantoin 100 mg Tab | As per BOQ specification | 1,200 | no | dglp171gem | 30 | |
| 95 | Omeprazole 20 mg Domperidone 10 mg Cap | As per BOQ specification | 600 | cap | dglp171gem | 30 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Key insights about JAMMU AND KASHMIR tender market
The eligibility requirements include being a registered entity, demonstrating a minimum average annual turnover of INR 2 Lakhs over the past three years, and having at least three years of relevant experience in supplying similar products to government or public sector organizations.
Bidders must upload several documents including experience criteria, past performance records, bidder turnover details, OEM authorization certificates, and compliance documents aligning with the specifications outlined in the BoQ.
Interested participants must register on the GeM portal, providing all necessary details, after which they can submit their bid documents per the guidelines specified in the tender.
The tender documentation should be submitted in specified formats outlined in the bid document, including PDF and other compatible formats as advised by the GeM guidelines.
Bidders must satisfy the technical specifications detailed in the tender document, ensuring that the supplied products meet regulatory standards for safety and efficacy.
All participating suppliers must comply with the high-quality standards as set forth in the tender specifications, which are critical for health-related products.
Yes, bidders need to comply with all specified regulatory norms, including documentation reflecting adherence to 'Make in India' policies and relevant governmental healthcare regulations.
Products will be evaluated based on compliance with the quality standards, as well as successful testing procedures ensuring they meet the safety and efficacy requirements set by the Department of Military Affairs.
The EMD has been waived for this tender to encourage wider participation, notably benefiting small and micro enterprises.
A performance security in the form of a bank guarantee is required for a period of eight months from the date of contract signing.
Payment details will be defined in the tender document, typically involving milestone payments upon receipt and inspection of goods delivered to designated military facilities.
The evaluation will consider the item-wise price with emphasis on competitive pricing as well as adherence to the quality and technical specifications defined by the tender.
All bids must be submitted electronically through the GeM portal, following the prescribed submission methods to ensure transparency and security of the bidding process.
Specific timelines will be mentioned in the bid document, and bidders must adhere strictly to these deadlines to ensure their proposals are considered.
The evaluation process will be conducted item-wise with a focus on quality, cost, and compliance with the tender requirements, with results communicated to all bidders after completion.
Bidders will be notified of the results promptly following the evaluation process, as per the standard protocols for such procurement processes.
MSEs can avail of exemptions from the experience and turnover criteria, provided they meet other product specifications, fostering greater inclusivity in the procurement process.
Startups are exempted from certain turnover requirements, allowing them to participate based on their innovative contributions, should they meet the necessary health service quality standards.
The procurement aims to give preference to local suppliers by stipulating minimum local content requirements for the products supplied, supporting the broader goals of self-reliance in health services.
Sign up now to access all documents
Main Document
OTHER
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS